KwdFr.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « KwdFr.i » - entrée « Amyloïdose () »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Amyloïdose < Amyloïdose () < Amyloïdose (anatomopathologie)  Facettes :

List of bibliographic references indexed by Amyloïdose ()

Number of relevant bibliographic references: 20.
Ident.Authors (with country if any)Title
000823 (2019) H. Shimagami [Japon] ; Y. Katada [Japon]Successful treatment with tocilizumab for massive ascites due to secondary amyloidosis complicating rheumatoid arthritis: a case report.
000F47 (2019) Erika Aikawa [Japon] ; Toshimasa Shimizu [Japon] ; Tomohiro Koga [Japon] ; Yushiro Endo [Japon] ; Masataka Umeda [Japon] ; Tomoko Hori [Japon] ; Junji Irie [Japon] ; Kishio Kuroda [Japon] ; Mizuna Eguchi [Japon] ; Momoko Okamoto [Japon] ; Sosuke Tsuji [Japon] ; Ayuko Takatani [Japon] ; Takashi Igawa [Japon] ; Remi Sumiyoshi [Japon] ; Shin-Ya Kawashiri [Japon] ; Naoki Iwamoto [Japon] ; Kunihiro Ichinose [Japon] ; Mami Tamai [Japon] ; Hideki Nakamura [Japon] ; Tomoki Origuchi [Japon] ; Atsushi Kawakami [Japon]Atypical Familial Mediterranean Fever Complicated with Gastrointestinal Amyloidosis Diagnosed due to Paroxysmal Arthralgia and Intractable Diarrhea, Successfully Treated with Tocilizumab.
001375 (2018) Yasuaki Okuda [Japon] ; Toshiyuki Yamada [Japon] ; Mitsuharu Ueda [Japon] ; Yukio Ando [Japon]First Nationwide Survey of 199 Patients with Amyloid A Amyloidosis in Japan.
001600 (2017) Hiroshi Uda [Japon] ; Osamu Saiki [Japon]Tocilizumab postpones the start of hemodialysis compared to conventional oral treatment in amyloid A amyloidosis patients with advanced renal insufficiency by suppressing serum SAA levels.
001867 (2017) Songkiat Chantarogh [Thaïlande] ; Soamarat Vilaiyuk [Thaïlande] ; Thipwimol Tim-Aroon [Thaïlande] ; Suchin Worawichawong [Thaïlande]Clinical improvement of renal amyloidosis in a patient with systemic-onset juvenile idiopathic arthritis who received tocilizumab treatment: a case report and literature review.
001B32 (2016) Jaka Ostrovršnik [Slovénie] ; Alojzija Ho Evar [Slovénie] ; Boris Lestan [Slovénie] ; Snežna Sodin Emrl [Slovénie] ; Katja Lakota [Slovénie] ; Matija Tomši [Slovénie]Long-term follow-up on tocilizumab treatment of AA amyloidosis secondary to polyarteritis nodosa.
001E66 (2015) Tadahiko Tamura [Japon] ; Shinobu Tamura [Japon] ; Hironori Tanaka [Japon] ; Yuko Ohagi [Japon] ; Fumitaka Taniguchi [Japon] ; Hirofumi Yamanishi [Japon] ; Toshihisa Kohara [Japon] ; Ritsuko Kimura [Japon] ; Toshio Kurihara [Japon] ; Takashi Ozaki [Japon] ; Yoshio Nakano [Japon] ; Tokuzo Fujimoto [Japon]Tocilizumab for intestinal amyloidosis complicated by multi-centric Castleman's disease.
001E68 (2015) Takashi Iijima [Japon] ; Junichi Hoshino ; Tatsuya Suwabe ; Keiichi Sumida ; Koki Mise ; Masahiro Kawada ; Toshiharu Ueno ; Satoshi Hamanoue ; Noriko Hayami ; Rikako Hiramatsu ; Naoki Sawa ; Kenmei Takaichi ; Yoshifumi UbaraTocilizumab for AA Amyloidosis after Treatment of Multicentric Castleman Disease with Steroids, Chemotherapy and Rituximab for Over 20 Years.
002212 (2015) Shunichi Fujita [Japon] ; Nami Kosaka [Japon] ; Takafumi Mito [Japon] ; Hiroaki Hayashi [Japon] ; Yoshitaka Morita [Japon]Development of aseptic subcutaneous abscess after tocilizumab therapy in a patient with SAPHO syndrome complicated by amyloid A amyloidosis
002344 (2014) Ippei Miyagawa [Japon] ; Shingo Nakayamada ; Kazuyoshi Saito ; Kentaro Hanami ; Masao Nawata ; Norifumi Sawamukai ; Kazuhisa Nakano ; Kunihiro Yamaoka ; Yoshiya TanakaStudy on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis.
002475 (2014) Yasuaki Okuda [Japon] ; Makoto Ohnishi ; Kenichiro Matoba ; Kazuo Jouyama ; Akihiro Yamada ; Naoya Sawada ; Sho Mokuda ; Yousuke Murata ; Kiyoshi TakasugiComparison of the clinical utility of tocilizumab and anti-TNF therapy in AA amyloidosis complicating rheumatic diseases.
002670 (2013) M D Redondo-Pach N [Espagne] ; R. Enríquez ; A E Sirvent ; E. Andrada ; R. Noguera-Pons ; I. Millán ; F. Amor STocilizumab treatment for nephrotic syndrome due to amyloidosis in Behcet's disease.
002823 (2013) L. Aguado-Gil [Espagne] ; I. Irarrazaval-Armendáriz ; M. Pretel-IrazabalAdvances in the diagnosis and treatment of tumor necrosis factor receptor-associated periodic syndrome.
002866 (2013) Markku Hakala [Finlande] ; Kai Immonen [Finlande] ; Markku Korpela [Finlande] ; Mikko Vasala [Finlande] ; Markku J. Kauppi [Finlande]Good medium-term efficacy of tocilizumab in DMARD and anti-TNF-α therapy resistant reactive amyloidosis
003890 (2011) Dai Kishida [Japon] ; Yasuaki Okuda ; Makoto Onishi ; Masashi Takebayashi ; Kenichiro Matoba ; Kazuo Jouyama ; Akihiro Yamada ; Naoya Sawada ; Sho Mokuda ; Kiyoshi TakasugiSuccessful tocilizumab treatment in a patient with adult-onset Still's disease complicated by chronic active hepatitis B and amyloid A amyloidosis.
003940 (2011) K. Immonen ; M. Kauppi ; M. HakalaExperiences on the use of biological drugs in psoriatic arthritis-associated amyloidosis.
003D86 (2010) Daichi Inoue [Japon] ; Hiroshi Arima [Japon] ; Chiharu Kawanami [Japon] ; Yoko Takiuchi [Japon] ; Seiji Nagano [Japon] ; Takaharu Kimura [Japon] ; Sonoko Shimoji [Japon] ; Minako Mori [Japon] ; Sumie Tabata [Japon] ; Soshi Yanagita [Japon] ; Akiko Matsushita [Japon] ; Kenichi Nagai [Japon] ; Yukihiro Imai [Japon] ; Takayuki Takahashi [Japon]Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis
003F74 (2009) Hiroe Sato [Japon] ; Takehito Sakai [Japon] ; Toshiaki Sugaya [Japon] ; Yasuhiro Otaki [Japon] ; Kana Aoki [Japon] ; Katsushi Ishii [Japon] ; Hidehiro Horizono [Japon] ; Hiroshi Otani [Japon] ; Asami Abe [Japon] ; Noboru Yamada [Japon] ; Hajime Ishikawa [Japon] ; Kiyoshi Nakazono [Japon] ; Akira Murasawa [Japon] ; Fumitake Gejyo [Japon]Tocilizumab dramatically ameliorated life-threatening diarrhea due to secondary amyloidosis associated with rheumatoid arthritis
004244 (2006) Yasuaki Okuda [Japon] ; Kiyoshi Takasugi [Japon]Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis
004376 (????) Liliana Dinoia [Italie] ; Giuseppe Lopalco [Italie] ; Luca Cantarini [Italie] ; Loreto Gesualdo [Italie] ; Michele Rossini [Italie] ; Florenzo Iannone [Italie]Long-term tocilizumab efficacy in a patient with psoriatic arthritis and AA amyloidosis.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Amyloïdose ()" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Amyloïdose ()" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Amyloïdose ()
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021